银诺医药－Ｂ(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02591 银诺医药－Ｂ

交易中 12-05 14:44:41

44.600

+3.260

+7.89%

最高44.920	最低41.360	成交量74.26万
今开41.360	昨收41.340	日振幅8.61%
总市值203.74亿	流通市值187.45亿	总股本4.57亿
成交额3,260万	换手率0.18%	流通股本4.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"银诺医药－Ｂ","latestPrice":44.6,"timestamp":1764917077935,"preClose":41.34,"halted":0,"volume":742600,"delay":0,"floatShares":420285370,"shares":456819349,"eps":-0.4586275611056622,"marketStatus":"交易中","change":3.26,"latestTime":"12-05 14:44:41","open":41.36,"high":44.92,"low":41.36,"amount":32602862,"amplitude":0.086115,"askPrice":44.66,"askSize":1800,"bidPrice":44.52,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.5816711046891785,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1764922200000},"marketStatusCode":2,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":41.34,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":2.007461,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02591","defaultTab":"news","newsList":[{"id":"2589854273","title":"港股异动 | 银诺医药-B(02591)再涨超5% 下周一正式进入恒生综指 机构称其符合港股通纳入范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2589854273","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589854273?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:05","pubTimestamp":1764900344,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B(02591)再涨超5%，股价暂现三连阳。截至发稿，涨5.03%，报43.42港元，成交额764.33万港元。消息面上，恒生指数系列季度检讨结果此前公布，其中，银诺医药获纳入恒生综合指数成份股，变动将于2025年12月8日起生效。据中金预测，银诺医药等符合港股通纳入范围。公开资料显示，银诺医药是一家专注于代谢性疾病领域的生物医药公司，目前拥有多项针对糖尿病、肥胖和非酒精性脂肪性肝炎等适应症的创新药物研发管线，全部为自主研发，具备全球知识产权，覆盖全球研发与市场布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2588882596","title":"银诺医药-B12月04日获主力加仓73.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588882596","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588882596?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:16","pubTimestamp":1764836164,"startTime":"0","endTime":"0","summary":"12月04日, 银诺医药-B股价涨5.41%，报收41.34元，成交金额1978.7万元，换手率0.12%，振幅6.17%，量比0.76。银诺医药-B今日主力资金净流入73.2万元，连续3日净流入，上一交易日主力净流入67.3万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为100.00%，平均涨幅为3.45%。该股近5个交易日下跌5.57%，主力资金累计净流入309.0万元；近20日主力资金累计净流入3187.8万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204162247a723519b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204162247a723519b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":1},{"id":"1153185179","title":"广州银诺医药（2591）11月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1153185179","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153185179?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:03","pubTimestamp":1764752618,"startTime":"0","endTime":"0","summary":"广州银诺医药集团股份有限公司于2025年12月3日发布2025年11月股份变动月报。公告显示，截至2025年11月30日，公司注册股本为人民币456,819,349元，包括420,285,370股在香港联交所上市的H股及36,533,979股非上市股份，面值均为每股人民币1元；本月内上述股数无增减变动。根据公告所载信息，本次月报由公司联席公司秘书金今签署，公司确认已遵守香港联交所上市规则及相关法律法规。综上所述，截至2025年11月末，公司股本保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2588028481","title":"银诺医药-B12月03日获主力加仓67.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588028481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588028481?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749756,"startTime":"0","endTime":"0","summary":"12月03日, 银诺医药-B股价涨3.65%，报收39.22元，成交金额1432.3万元，换手率0.09%，振幅5.44%，量比0.51。银诺医药-B今日主力资金净流入67.3万元，上一交易日主力净流入33.5万元。该股近5个交易日下跌6.74%，主力资金累计净流入822.9万元；近20日主力资金累计净流入3370.9万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162123978d74d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162123978d74d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2588275897","title":"银诺医药-B(02591)及银诺技术合共认购1.25亿元宁波银行结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2588275897","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588275897?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:34","pubTimestamp":1764592470,"startTime":"0","endTime":"0","summary":"智通财经APP讯，银诺医药-B(02591)公布，于2025年12月1日，公司及银诺技术(公司一间直接全资附属公司)以代价合共人民币1.25亿元(即其总本金额)分别向宁波银行认购一款结构性存款产品(即宁波银行结构性存款产品)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0201","SGXZ49509284.SGD","LU1720050803.USD","BK0188","BK0187","LU1969619763.USD","002142","BK0028","LU2097828631.EUR","BK0278","LU2097828557.USD","BK0183","LU1688375341.USD","LU1794554557.SGD","LU2097828714.EUR","LU1820825898.SGD","LU0140636845.USD","BK1161","LU1655091616.SGD","LU2097828805.USD","LU2328871848.SGD","LU1146622755.USD","02591","LU2580892862.HKD","LU2580892789.USD","SGXZ81163826.USD","BK0197","LU2097828474.EUR"],"gpt_icon":0},{"id":"1157495277","title":"银诺医药－Ｂ：12月1日认购结构性存款产品，金额达1.25亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1157495277","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157495277?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:34","pubTimestamp":1764592449,"startTime":"0","endTime":"0","summary":"银诺医药－Ｂ于12月1日认购了金额为1.25亿元人民币的结构性存款产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"gpt_icon":0},{"id":"1177974852","title":"一周港股牛熊榜 | 恒生综合指数新贵银诺医药、禾赛分别飙51%、25%；机器人概念热炒、广汽集团一周升31%；深陷债务泥潭、万科企业跌13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177974852","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177974852?lang=zh_cn&edition=full","pubTime":"2025-11-28 19:00","pubTimestamp":1764327644,"startTime":"0","endTime":"0","summary":"消息面上，11月21日，恒生指数公司发布季度检讨结果，相关变动将于2025年12月5日收市后实施，并于2025年12月8日起生效。第三季度，公司经调整利润达2410.8万美元，同比增长126.0%，环比增长51.0%。11月27日，万科A股大跌超过7%。11月12日，万科公告称，深铁集团向其提供了不超过16.66亿元借款。目前，万科亏损较大。2025年前三季度，万科实现营业收入1613.9亿元，同比下降26.61%；净利润亏损280.2亿元。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"634cd6212949dd3f0bfe745f2cf2a7d9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一周港股牛熊榜 | 恒生综合指数新贵银诺医药、禾赛分别飙51%、25%；机器人概念热炒、广汽集团一周升31%...","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01735","01729","02238","02525","02202","01860","02570","02591","01384","00108"],"gpt_icon":1},{"id":"2587975270","title":"银诺医药-B11月28日获主力加仓181.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2587975270","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587975270?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:15","pubTimestamp":1764317749,"startTime":"0","endTime":"0","summary":"11月28日, 银诺医药-B股价涨0.37%，报收43.94元，成交金额2013.5万元，换手率0.11%，振幅9.18%，量比0.53。银诺医药-B今日主力资金净流入181.2万元，连续3日净流入，上一交易日主力净流入587.2万元。该股近5个交易日上涨51.80%，主力资金累计净流入1668.3万元；近20日主力资金累计净流入3488.6万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112816231297845f03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112816231297845f03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2586413213","title":"港股异动 | 银诺医药-B(02591)再涨近7% 四个交易日股价累涨超50% 将被纳入恒生综合指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2586413213","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586413213?lang=zh_cn&edition=full","pubTime":"2025-11-27 11:52","pubTimestamp":1764215566,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B(02591)再涨近7%，四个交易日股价累计涨超50%。截至发稿，涨6.79%，报44.68港元，成交额3536.66万港元。消息面上，11月21日，恒生指数系列季度检讨结果出炉，其中，银诺医药获纳入恒生综合指数成份股，变动将于2025年12月8日起生效。据中金预测，银诺医药等符合港股通纳入范围。据悉，银诺医药是一家专注于代谢性疾病领域的生物医药公司，目前拥有多项针对糖尿病、肥胖和非酒精性脂肪性肝炎等适应症的创新药物研发管线，全部为自主研发，具备全球知识产权，覆盖全球研发与市场布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02591","HSCI"],"gpt_icon":0},{"id":"2586438624","title":"港股异动 | 银诺医药-B(02591)再涨超6% 昨日股价飙涨超30% 公司获纳入恒生综指","url":"https://stock-news.laohu8.com/highlight/detail?id=2586438624","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586438624?lang=zh_cn&edition=full","pubTime":"2025-11-25 11:28","pubTimestamp":1764041311,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B(02591)再涨超6%，昨日股价飙涨超30%。截至发稿，涨6.11%，报40.3港元，成交额2313.13万港元。消息面上，11月21日，恒生指数系列季度检讨结果出炉，所有变动将于2025年12月8日起生效。其中，银诺医药获纳入恒生综合指数成份股。上海证券此前研报指出，银诺医药依苏帕格鲁肽α具有良好的安全性和降糖、减重效果，在治疗糖尿病、肥胖、脂肪肝等慢性代谢性疾病方面表现显著优势，公司登陆港交所有望推进研发管线及商业化拓展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 银诺医药-B(02591)再涨超6% 昨日股价飙涨超30% 公司获纳入恒生综指","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2586141638","title":"银诺医药-B11月24日主力净流入448.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586141638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586141638?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:15","pubTimestamp":1763972135,"startTime":"0","endTime":"0","summary":"11月24日, 银诺医药-B股价涨31.15%，报收37.98元，成交金额4156.0万元，换手率0.28%，振幅32.80%，量比2.78。银诺医药-B今日主力资金净流入448.4万元，上一交易日主力净流出30.5万元。该股近5个交易日上涨10.15%，主力资金累计净流入814.4万元，其中3个交易日为股价下跌时净流入；近20日主力资金累计净流入2267.8万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124161842a4b69b65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124161842a4b69b65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2585843451","title":"港股异动 | 银诺医药-B(02591)涨近10% 获纳入恒生综合指数 12月8日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=2585843451","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585843451?lang=zh_cn&edition=full","pubTime":"2025-11-24 10:12","pubTimestamp":1763950333,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B涨近10%，截至发稿，涨9.81%，报31.8港元，成交额276.93万港元。消息面上，11月21日，恒生指数系列季度检讨结果出炉，所有变动将于2025年12月8日起生效。其中，银诺医药获纳入恒生综合指数成份股。今年9月，银诺医药发布公告称，公司已在中国完成核心产品用于治疗肥胖和超重的III期临床试验的首例患者给药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSCI","02591","BK1161"],"gpt_icon":0},{"id":"2585113602","title":"智通港股52周新高、新低统计|11月21日","url":"https://stock-news.laohu8.com/highlight/detail?id=2585113602","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585113602?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:40","pubTimestamp":1763714401,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止11月21日收盘，有14只股票创52周新高，其中恒发光学、朝威控股、木薯资源创高率位于前3位，分别为42.11%、30.56%、22.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01653","00180","00610","06687","00638","02453","00500","00341","06960","01268","01773","00841","01498","00599","01745","02543","00040","02591","02246","01304","02587","01855","02535","02011","02818","01119","02431","00325","01865","00917","01274","09878","03880","09688","01004","00182","08500","01134","00397","01029","01121","06603","02367","01830","00848","02508","00314","00699","02515"],"gpt_icon":1},{"id":"2584994008","title":"银诺医药-B股价大跌5.42% 依苏帕格鲁肽αIII期临床试验完成首例给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2584994008","media":"港美通","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584994008?lang=zh_cn&edition=full","pubTime":"2025-11-19 10:32","pubTimestamp":1763519571,"startTime":"0","endTime":"0","summary":"11月19日10:23，银诺医药-B(02591)股价大幅下跌5.42%。该股报32.120港元，最高报33.960港元，最低报32.120港元，成交量10.74万股，成交额353.47万港元。消息面上，银诺医药-B近日发布公告称，公司核心产品依苏帕格鲁肽α用于治疗肥胖和超重的III期临床试验已完成首例患者给药。广州银诺医药集团股份有限公司是一家科学驱动的生物制药公司,致力于为代谢性疾病患者提供创新的,可及且可负担的高质量药品。公司目前已拥有多项针对糖尿病、肥胖,代谢功能障碍相关适应症的研发管线,且所有管线均为自主研发,拥有全球专利,并布局全球研发和市场销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119104017950d742c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119104017950d742c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2584449679","title":"银诺医药-B11月17日获主力加仓221.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584449679","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584449679?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:15","pubTimestamp":1763367315,"startTime":"0","endTime":"0","summary":"11月17日, 银诺医药-B股价涨4.61%，报收34.48元，成交金额1475.3万元，换手率0.10%，振幅4.73%，量比1.00。银诺医药-B今日主力资金净流入221.1万元，连续5日净流入，上一交易日主力净流入26.6万元。该股近5个交易日上涨6.25%，主力资金累计净流入1119.3万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1453.3万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117161557a4a72124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117161557a4a72124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2583502545","title":"银诺医药-B11月14日获主力加仓26.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583502545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583502545?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:15","pubTimestamp":1763108152,"startTime":"0","endTime":"0","summary":"11月14日, 银诺医药-B股价涨2.30%，报收32.96元，成交金额1410.6万元，换手率0.10%，振幅7.08%，量比1.00。银诺医药-B今日主力资金净流入26.6万元，连续4日净流入，上一交易日主力净流入194.2万元。该股近5个交易日上涨9.87%，主力资金累计净流入893.2万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1232.3万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511141621399768f4c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511141621399768f4c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"1133726470","title":"港股生物医药板块午后走强！歌礼制药-B涨超10%，圣诺医药-B涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133726470","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133726470?lang=zh_cn&edition=full","pubTime":"2025-11-10 14:00","pubTimestamp":1762754453,"startTime":"0","endTime":"0","summary":"11月10日，港股生物医药板块午后走强，$歌礼制药-B(01672)$涨超10%，$圣诺医药-B(02257)$涨超8%，银诺医药-B、开拓药业-B、$劲方医药-B(02595)$、$映恩生物-B(09606)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"afa821d7c5aabc22fa508f3ca44a801f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","02595","09606","01672","01477","02257","09939"],"gpt_icon":0},{"id":"2582330813","title":"银诺医药亮相第八届进博会：以医保数据驱动研发，引领糖尿病治疗新方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2582330813","media":"银诺医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582330813?lang=zh_cn&edition=full","pubTime":"2025-11-10 11:56","pubTimestamp":1762746992,"startTime":"0","endTime":"0","summary":"在上海市、区医保部门的指导及支持下，银诺医药作为医保数据赋能创新药物研发的实践典范，亮相第八届中国国际进口博览会国家医保展区，并成为该展区首个医保数据运用在真实世界数据研究的展示案例。然而，长期以来，国内缺乏大规模、高质量的真实世界研究数据，难以系统评估2型糖尿病患者的治疗现状，也难以有效指导新药研发方向。在此背景下，医保数据为破解真实世界研究瓶颈、驱动研发决策提供了全新路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110202835a4974bdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110202835a4974bdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2581583580","title":"银诺医药-B11月07日主力净流出88.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2581583580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581583580?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:15","pubTimestamp":1762503355,"startTime":"0","endTime":"0","summary":"11月07日, 银诺医药-B股价跌1.96%，报收30.00元，成交金额1304.9万元，换手率0.10%，振幅3.14%，量比1.10。银诺医药-B今日主力资金净流出88.7万元，上一交易日主力净流入256.3万元。该股近5个交易日下跌1.90%，主力资金累计净流入340.0万元；近20日主力资金累计净流入376.6万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107162148975a192b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107162148975a192b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2581790043","title":"银诺医药-B11月06日获主力加仓256.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581790043","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581790043?lang=zh_cn&edition=full","pubTime":"2025-11-06 16:15","pubTimestamp":1762416950,"startTime":"0","endTime":"0","summary":"11月06日, 银诺医药-B股价涨0.46%，报收30.60元，成交金额1326.6万元，换手率0.10%，振幅7.22%，量比1.10。银诺医药-B今日主力资金净流入256.3万元，上一交易日主力净流入141.4万元。该股近5个交易日上涨2.21%，主力资金累计净流入428.6万元；近20日主力资金累计净流入401.8万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106162050a6e55f71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106162050a6e55f71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0557},{"period":"1month","weight":0.378},{"period":"3month","weight":-0.0029},{"period":"6month","weight":1.2131},{"period":"ytd","weight":1.2131}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"银诺医药成立于2014年,是一家科学驱动的生物制药公司,致力于为代谢性疾病患者提供创新的,可及且可负担的高质量药品。公司目前已拥有多项针对糖尿病、肥胖,代谢功能障碍相关适应症的研发管线,且所有管线均为自主研发,拥有全球专利,并布局全球研发和市场销售。\n公司首个管线产品依苏帕格鲁肽α(曾用名:苏帕鲁肽,商品名:怡诺轻)于2025年1月份获中国国家药品监督管理局批准上市,成为我国首个国产原研的人源化长效GLP-1受体激动剂产品,将惠及更多的糖尿病患者。公司同时在开发依苏帕格鲁肽α减肥和代谢功能障碍相关的脂肪性肝炎适应症,以满足这些疾病领域巨大的未满足治疗需求。\n银诺研发团队由国家特聘专家领衔,与具有多年创新药研发经验的科学家队伍组成,其创始人,董事长兼首席执行官,依苏帕格鲁肽α发明人王庆华博士是复旦大学特聘专家,十三五国家科技“重大新药创制”项目课题负责人。王庆华教授曾是多伦多大学的终身教授及世界领先的班廷百思特糖尿病研究所的常务委员。\n银诺医药拥有先进的重组蛋白生物药技术平台可用于创新生物药的持续研发。","exchange":"SEHK","name":"银诺医药－Ｂ","nameEN":"INNOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"银诺医药－Ｂ(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供银诺医药－Ｂ(02591)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"银诺医药－Ｂ,02591,银诺医药－Ｂ股票,银诺医药－Ｂ股票老虎,银诺医药－Ｂ股票老虎国际,银诺医药－Ｂ行情,银诺医药－Ｂ股票行情,银诺医药－Ｂ股价,银诺医药－Ｂ股市,银诺医药－Ｂ股票价格,银诺医药－Ｂ股票交易,银诺医药－Ｂ股票购买,银诺医药－Ｂ股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"银诺医药－Ｂ(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供银诺医药－Ｂ(02591)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}